Trial on hepatitis B treatment and its broader effects
Part of Digestive system, Infections clinical trials.
This study looks at how treating chronic hepatitis B affects people's daily lives, not just their liver health. It aims to understand the good and bad impacts from a patient's perspective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B (HBsAg positive for at least 6 months)
- You are 18 years or older
- You are a migrant to the UK (born outside the UK, or a non-UK citizen)
- You can speak and understand English well enough to give consent
- You are either starting hepatitis B treatment for the first time, or have been on oral treatment for at least a year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial looks at people with long-term hepatitis B infection and studies how treatment may affect health over time. It may help you understand whether your care improves outcomes for chronic hepatitis B.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
Hear when a new Hepatitis B Virus (HBV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.